State Street’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-72,186
Closed -$32.3K 4894
2022
Q4
$32.3K Hold
72,186
﹤0.01% 4654
2022
Q3
$35K Hold
72,186
﹤0.01% 4735
2022
Q2
$36K Buy
72,186
+59,800
+483% +$29K ﹤0.01% 4794
2022
Q1
$8K Buy
12,386
+1,781
+17% +$934 ﹤0.01% 4909
2021
Q4
$7K Hold
10,605
﹤0.01% 4790
2021
Q3
$36K Hold
10,605
﹤0.01% 4664
2021
Q2
$40K Sell
10,605
-72,025
-87% -$298K ﹤0.01% 4446
2021
Q1
$512K Buy
82,630
+8,827
+12% +$78.2K ﹤0.01% 3730
2020
Q4
$580K Buy
+73,803
New +$677K ﹤0.01% 3628

Other funds holding MTCR

State Street's MTCR Position: Q1 2023 in Review

State Street sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 72,186 shares — an estimated $32.3K sold.

State Street first reported a position in MTCR in Q4 2020 and held it in 9 quarters. The position peaked at $580K in Q4 2020. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.

  • State Street reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • State Street sold 72,186 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $32.3K.
  • State Street first reported a position in Metacrine, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • State Street's Metacrine, Inc. Common Stock position peaked at $580K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.